Preferred Label : Anti-CD123/TOP1i Antibody-drug Conjugate AZD9829;
NCIt synonyms : Anti-CD123/TOP1i ADC AZD9829; Anti-CD123 ADC AZD9829; Anti-CD123 Antibody-drug Conjugate AZD9829;
NCIt definition : An antibody-drug conjugate (ADC) consisting of a monoclonal antibody against the interleukin-3
(IL3)-receptor alpha chain (CD123; IL-3RA) conjugated to a topoisomerase-1 inhibitor
(TOP1i), with potential antineoplastic activity. Upon administration of anti-CD123/TOP1i
ADC AZD9829, the antibody moiety targets and binds to the cell surface antigen CD123
expressed on tumor cells. Upon binding and internalization, the TOP1i moiety is released,
binds to TOP1 and stabilizes cleaved DNA-TOP1 complexes. This prevents DNA re-ligation,
induces irreversible DNA strand breaks, prevents DNA repair, and leads to cycle arrest
and apoptosis specifically in tumor cells expressing CD123. CD123 regulates the proliferation,
survival and differentiation of hematopoietic cells. CD123 is overexpressed on a variety
of cancers, including myeloid leukemia, and increased expression of CD123 on leukemic
stem cells is associated with poor prognosis.;
Molecule name : AZD 9829; AZD-9829;
NCI Metathesaurus CUI : CL1922701;
Origin ID : C203509;
UMLS CUI : C5908004;
Semantic type(s)
- concept_is_in_subset
- has_target
